PERFIL EPIDEMIOLÓGICO DAS INTERNAÇÕES HOSPITALARES POR GLAUCOMA NO ESTADO DO RIO GRANDE DO SUL
PERFIL EPIDEMIOLÓGICO DAS INTERNAÇÕES HOSPITALARES POR GLAUCOMA NO ESTADO DO RIO GRANDE DO SUL
-
DOI: https://doi.org/10.22533/at.ed.07624120614
-
Palavras-chave: Glaucoma, Perfil Epidemiológico
-
Keywords: Glaucoma, Epidemiological Profile
-
Abstract: Glaucoma is characterized by anatomical and functional changes which result in progressive loss of retinal ganglion cells and damage to the optic nerve. This optic neuropathy represents a silent threat to visual health, often triggering irreversible damage even before it is detected. Due to the impact it has on society and on public health, it was deemed of utmost relevance to identify the epidemiological profile of hospital admissions due to glaucoma in the state of Rio Grande do Sul. A cross-sectional descriptive study was carried out based on data from the Department of Informatics of the Unified Health System (DATASUS). Data was found regarding the number of deaths, sex, age group and race of patients hospitalized for glaucoma between the years 2011 and 2020. In total, 808 hospitalizations due to glaucoma were recorded in the state, with the years 2018 and 2019 being particularly worthy of note, with 176 (21.78%) and 195 (24.13%) hospitalizations, respectively. Out of these cases, 429 were patients of the female sex, representing 53.09% of the overall total. Concerning age groups, the group between 60 and 69 years of age had the highest number of hospitalizations, equivalent to 27.72% of those services, while the group between 20 and 29 years of age had the lowest, representing less than 5% of this total. Regarding color/race, 176 records did not contain this information and, of the available records, the most affected group was Caucasian with 504 cases respectively. The results suggest a continued need for surveillance and for public health strategies to address this disease, particularly in older populations. The need to track the disease and carry out more detailed studies has been identified, so that diagnoses can be made early and that by monitoring the progression of the disease, a better quality of life can be guaranteed for patients.
- Ana Carolina Ballesteiros Paglioli
- Adriana d’Azevedo Panazzolo
- Ana Carolina Stradolini Volkmer
- Amira Abed
- Carolina Galarza Vargas
- Daniela Cunha Matter
- Eduardo Alfredo Caldas Queruz
- João Matas Kern
- Luiza Costa Gomes
- Neimah Maruf Ahmad Maruf Mahmud
- Raphaella Preissler Scherer
- Tahani Ibrahim Khalid